Sideris Pharmaceuticals' Series A Round

Sideris Pharmaceuticals raised a round of funding on October 22, 2013.

Sideris Pharmaceuticals is a privately held biopharmaceutical company that is focused on development of therapeutics for the treatment of transfusion-related iron overload. The company's operations in…

Articles about Sideris Pharmaceuticals' Series A Round: